Nuklearmedizin 1967; 06(03): 204-310
DOI: 10.1055/s-0037-1621338
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

125I-Sodium Iothalamate in the Determination of the Glomerular Filtration Rate

125I-iothalamate de soude pour la détermination de la filtration glomérulaire 125J-Natriumiothalamat zur Bestimmung der glomerulären Filtrationsrate
B. Malamos
1   From the Athens University Department of Clinical Therapeutics (Prof. B. Malamos) „Alexandra“ Hospital, Athens, Greece
,
A. S. Dontas
1   From the Athens University Department of Clinical Therapeutics (Prof. B. Malamos) „Alexandra“ Hospital, Athens, Greece
,
D. A. Koutras
1   From the Athens University Department of Clinical Therapeutics (Prof. B. Malamos) „Alexandra“ Hospital, Athens, Greece
,
S. Marketos
1   From the Athens University Department of Clinical Therapeutics (Prof. B. Malamos) „Alexandra“ Hospital, Athens, Greece
,
J. Sfontouris
1   From the Athens University Department of Clinical Therapeutics (Prof. B. Malamos) „Alexandra“ Hospital, Athens, Greece
,
N. Papanicolaou
1   From the Athens University Department of Clinical Therapeutics (Prof. B. Malamos) „Alexandra“ Hospital, Athens, Greece
› Author Affiliations
Further Information

Publication History

Received: 12 May 1967

Publication Date:
05 February 2018 (online)

Summary

One hundred 125I-sodium iothalamate and endogenous creatinine clearances in 36 subjects were compared with standard inulin clearance measurements. There was a very close correlation of the urine/plasma ratios between any two of the three clearances studied, hence both labelled iothalamate and creatinine can be relied upon for the estimation of the glomerular filtration rate in clinical practice. The mean ratio of 125I-sodium iothalamate to inulin clearance was 1.01 and that of creatinine to inulin 1.03. It is concluded that the clearance of 125I-sodium iothalamate can be substituted for the clearance of inulin in clinical determinations of the glomerular filtration rate but that in centres without radioisotope facilities the endogenous creatinine clearance can be used instead.

Chez 36 sujets, 100 déterminations de la clearance du 125I-iothalamate de soude et de celle de la créatinine endogène ont été faites simultanément avec des déterminations de la clearance d’inuline en vue de les comparer. Les quotients urine : plasma des concentrations de chacune de ces trois substances avaient une corrélation très étroite, et par conséquent en pratique clinique, la détermination de la filtration glomérulaire peut s’effectuer avec de l’iothalamate de soude ou avec de la créatinine. La valeur moyenne du quotient clearance de l’iothalamate/clearance de l’inuline était de 1.01, celle du quotient clearance de la créatinine/clearance de l’inuline de 1.03. Il est évident que la clearance du 125I-iothalamate de soude pourrait remplacer celle de l’inuline pour la détermination de la filtration glomerulaire en clinique. Dans l’absence de laboratoires isotopiques, cependant, la clearance de la créatinine endogène peut aussi être employée.

An 36 Personen wurden 100 125J-Natriumiothalamat- und endogene Kreatinin-Clearances bestimmt und mit gleichzeitig durchgeführten Inulin-Clearancebestimmungen verglichen. Der Urin-Plasma-Quotient zeigte eine sehr gute Korrelation zwischen je zwei der drei untersuchten Clearancemethoden, so daß beide Methoden, die nuklearmedizinische und die chemische, zur Bestimmung der glomerulären Filtration in der klinischen Praxis verwendet werden können. Der durchschnittliche 125J-Natriumiothalamat/Inulin Clearance-Quotient betrug 1.01, der durchschnittliche endogene Kreatinin/Inulin Clearance-Quotient betrug 1.03. Es wird daraus geschlossen, daß die 125J-Natriumiothalamat Clearance bei der klinischen Bestimmung des Glomerulusfiltrats die Inulin-Clearance ersetzen kann. In Zentren, die über keine Möglichkeit der Anwendung von Radioisotopen verfügen, kann stattdessen die endogene Kreatinin-Clearance verwandt werden.

 
  • References

  • 1 Bianchi C, Toni e P. La determinazione delle clearances renali mediante traccianti radioattivi. Minerva nefrol 10: 116 1963;
  • 2 Bonsnes R. W, Taussky H. H. On the determination of creatinine by the Jaffe reaction. J. biol. Chem 158: 581 1945;
  • 3 Brod J, Sirota J. H. The renal clearance of endogenous „creatinine“ in man. J. clin. Invest 27: 645 1948;
  • 4 Concannon J. P, Summers R. F, Brewer R, Cole C, Well C, Foster W. D. 125I-allyl inulin for the determination of glomerular filtration rates. Amer. J. Roentgenol 92: 302 1964;
  • 5 Cotlove E. 14C-carboxyl-labelled inulin as tracer for inulin. Fed. Proc 14: 32 1955;
  • 6 Doolan P. D, Alpen E. L, Theil G. B. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Amer. J. Med 32: 65 1962;
  • 7 Elwood C. M, Sigman E. M. The measurement of glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) in man by 125I-iothalamate and 131I-iodopyracet. In Third International Congress of Nephrology. 186 Washington: 1966
  • 8 Farmer C. D, Tauxe W. N, Maher F. T, Hunt J. C. Measurement of renal function with radioiodinated diatrizoate and o-iodohippurate. Amer. J. clin. Path 47: 9 1967;
  • 9 Foley T. H, Jones N. F, Clapham W. F. Renal clearance of 57Co cyanocobalamin. Importance of plasma protein binding. Lancet II: 86 1966;
  • 10 Griep R. J, Nelp W. B. Mechanism of renal excretion of iodine-131-sodium iothalamate (Conray). J. nucl. Med 7: 370 1966;
  • 11 Lancet Measurement of glomerular filtration-rate (Leading article). II: 276 1965;
  • 12 Malamos B, Dontas A. S, Koutras D. A, Marketos S, Sfontouris J, Papanicolaou N. The determination of glomerular filtration-rate in clinical practice. Lancet I: 943 1966;
  • 13 Meschan I, Deyton W. E, Schmid H. E, Watts F. C. The utilization of 131I labeled Renografin as an inulin substitute for renal clearance rate determination. Radiology 81: 974 1963;
  • 14 Meschan I, Wralls F. C, Lathem E, Boyce W. H, Schmid H. E, Maynard C. D, Hoper T, Hosick T. H. Simultaneous PAH, inulin and renografin-131I renal clearance determinations and a method for calculating renografin from renograms in patients. Am. J. Roentgenol 97: 909 1966;
  • 15 Miller B. F, Leaf A, Mamby A. R, Miller Z. Validity of the endogenous creatinine clearance as a measure of glomerular filtration in the diseased human kidney. J. clin. Invest 31: 309 1952;
  • 16 Morris A. M, Elwood C, Sigman E. M, Catanzaro A. The renal clearance of 131I-labeled meglumine diatrizoate (Renografin) in man. J. nucl. Med 6: 183 1965;
  • 17 Schreiner G. E. Determination of inulin by means of resorcinol. Proc. Soc. Exp. Biol. Med 74: 117 1950;
  • 18 Sigman E. M, Elwood C, Reagan M. E, Morris A. M, Catanzaro A. The renal clearance of 131I labelled sodium iothalamate in man. Invest. Urol 2: 432 1965;
  • 19 Sigman E. M, Elwood C, Knox F. The measurement of glomerular filtration rate in man with sodium iothalamate 131I (Conray). J. nucl. Med 7: 60 1966;
  • 20 Smith H. W. The Kidney: Structure and Function in Health and Disease. Oxford University Press; New York: 1951
  • 21 Stokes J. M, Conklin J. W, Huntley H. C. Measurement of glomerular filtration rate by contrast media containing 131I isotope. J. Urol 87: 630 1962;
  • 22 Tobias G. J, McLaughlin R. F, Hopper Jr. J.. Endogenous creatinine clearance. A valuable clinical test of glomerular filtration and a prognostic guide in chronic renal disease. New Engl. J. Med 266: 317 1962;
  • 23 de Wardener H. E. The Kidney: An Outline of Normal and Abnormal Structure and Function. Churchill; London: 1961
  • 24 Wrong O. M. In Renal Disease. edited by Black D. A. K. 440. Blackwell; Oxford: 1962